2024 - Bridging the Gaps: Diversity, Retention, and the Role of Optimized Trials in Modern Clinical Research

Discover an informative webinar that focuses on the advantages of blending decentralized clinical trial (DCT) elements with traditional site approaches to improve patient enrollment, retention and diversity, as well as how these trials capitalize on the patient–physician relationship to expedite the development of new therapies.
Clinical research is not functioning optimally. It takes 7-13 years to develop a new drug with 85 percent of trials missing their targeted timelines, most having less than 15 percent minority representation, and some having as high as a 30 percent dropout rate.1
Read more...
Register for this webinar today to explore the transformative potential of decentralized clinical trials and how optimized and virtual-first trials are addressing longstanding challenges in clinical research.
References
1 Only Elligo. Elligo Health Research. Accessed 2024 May 28.
2 Nov 2020 DCT Survey Report. PPD. Accessed 2024 May 28.
3 Nov 2023 Pulse Report. PPD. Accessed 2024 May 28.
Keywords: Clinical Trials, Drug Development, Clinical Research, Patient Recruitment, Clinical Trial Optimization, Decentralized Trials, Decentralized Clinical Trials, DCT, Clinical Trial Diversity, Sites